Angchaisuksiri P, Carlson P L, Dessypris E N
Hematology/Oncology Section, H.H. McGuire Veterans Affairs Medical Center, Richmond, Virginia 23249, USA.
Br J Haematol. 1996 Apr;93(1):13-7. doi: 10.1046/j.1365-2141.1996.4761013.x.
In serum-free cultures of human CD34 cells, recombinant human thrombopoietin (TPO) induced megakaryocyte colony formation a dose-dependent fashion that was further enhanced by the presence of interleukin-3 (IL-3) and stem cell factor (SCF), but not by IL-6, IL-11 or erythropoietin. TPO gave rise to much smaller colonies and at an earlier time than IL_3, indicating that TPO affects predominantly more mature megakaryocytic progenitors. In liquid cultures. TPO increased the percentage and the absolute number of > or = 8N megakaryocytes, but it did not shift their modal ploidy from 2N. TPO-induced endomitosis was totally inhibited by the presence of or previous exposure of cells to, IL-3 and /or SCF. The mechanism by which TPO overcomes in vivo the negative effects of IL-3 and SCF on megakaryocyte ploidy remains unknown.
在人CD34细胞的无血清培养中,重组人血小板生成素(TPO)以剂量依赖的方式诱导巨核细胞集落形成,白细胞介素-3(IL-3)和干细胞因子(SCF)的存在可进一步增强这种作用,但IL-6、IL-11或促红细胞生成素则无此作用。与IL-3相比,TPO产生的集落小得多且时间更早,这表明TPO主要影响更成熟的巨核细胞祖细胞。在液体培养中,TPO增加了≥8N巨核细胞的百分比和绝对数量,但未使其模式倍性从2N改变。TPO诱导的核内有丝分裂完全被细胞存在或预先暴露于IL-3和/或SCF所抑制。TPO在体内克服IL-3和SCF对巨核细胞倍性负面影响的机制尚不清楚。